Greystone Associates, July 2010
. Targetable and activatable imagingagents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare
Global Industry Analysts, Inc., Feb 2011, Pages: 449
This report analyzes the worldwide markets for ImagingAgents in US$ Million by the following product segments - Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals
Jain PharmaBiotech, Feb 2012, Pages: 1029
, there has been a considerable interest in developing rapid diagnostic methods for for point-of-care and biowarfare agents such as anthrax.
The number of companies involved in molecular diagnostics has
Global Industry Analysts, Inc., Oct 2011, Pages: 373
Market 82
Cardiovascular Imaging To Lead Volume Growth 82
Cardiolite Loses Market Share to Generics 82
Table 13: US Diagnostic Radiopharmaceutical Agents Market
(2010): Percentage Share Breakdown
Decision Resources, Inc., March 2010, Pages: 32
research on the safety of imagingagents, cross-collaboration between diagnosticimaging and pharmaceutical companies, and innovative solutions, such as picture archiving and communication systems (PACS), to integrate
Bizacumen Inc., Nov 2009, Pages: 252
Volume by Imaging Procedure in the US - 2009
Table 5: Percentage Share Breakdown of Diagnostic
Radiopharmaceutical Agents in the US - 2012
Table 6: Percentage Share Breakdown
Jain PharmaBiotech, Feb 2012, Pages: 772
of nanoparticles
Dendritic nanoprobes for imaging of angiogenesis
Gadolinium-loaded dendrimer nanoparticles for tumor-specific MRI
Gadonanotubes for MRI
Gold nanorods and nanoparticles as imagingagents
In vivo
Jain PharmaBiotech, Feb 2012, Pages: 639
of cancer
Nanobialys for combining MRI with delivery of anticancer agents
pHLIP nanotechnology for detection and targeted therapy of cancer
Radiolabeled carbon nanotubes for tumor imaging and targeting
JZMed Inc., Jan 2011, Pages: 282
and molecular biomarker, diagnostics and imaging
1. Genomics and proteomics are complementary to each other
2. Genomics and proteomics are technical basis of molecular biomarker, diagnostics and imaging
1
Business Insights, July 2010, Pages: 198
of a drug to its target, and the drug’s pharmacokinetic profile. In the clinical setting, imaging biomarkers can be used as a screening, diagnostic or prognostic tool as well as for monitoring treatment
Fuji-Keizai USA, Inc., Aug 2010, Pages: 171
Benefit Managers (PBM)
1.4 Drug/ Diagnostic Co-Development
1.4.1 Medical Conditions Targeted by Personalized Medicine
1.5 Status of Drug/ Diagnostic Co-Developed Products
1.5.1 Examples of Drug
Fuji-Keizai USA, Inc., Aug 2010, Pages: 155
Benefit Managers (PBM)
1.4 Drug/ Diagnostic Co-Development
1.4.1 Medical Conditions Targeted by Personalized Medicine
1.5 Status of Drug/ Diagnostic Co-Developed Products
1.5.1 Examples of Drug
Business Insights, June 2010, Pages: 250
– profiling and imaging
Protein, antibody, and aptamer arrays
Diagnostics in infectious diseases using proteomic techniques
Bacterial infections, proteomics, and diagnosis
MRSA and community- and hospital
TriMark Publications, July 2011, Pages: 201
A near-term market opportunity for cancer companion diagnostic tests exists in drug selection for cancer therapy. Co-development of molecular diagnostics and targeted therapeutics has already been
Decision Resources, Inc., Nov 2006, Pages: 32
and Other Parkinsonian Disorders
2. Select DiagnosticImagingAgents in Development, 2006
3. Strengths and Weaknesses of Current and Emerging Parkinson’s Disease Biomarkers
4. Select Biochemical
Jain PharmaBiotech, Feb 2012, Pages: 780
expression analysis
Monitoring in vivo gene expression by molecular imaging
Molecular imaging and personalized medicine
Glycomics-based diagnostics
Combination of diagnostics and therapeutics
Use
Decision Resources, Inc., May 2008, Pages: 32
for Cardiovascular Disease
6. Select Molecular ImagingAgents for Cardiovascular Disease
7. Select Diagnostics Partnerships for Cardiac Biomarker Technology, 2006-2007
Figures
1. Development Process of Coronary
Life Science Intelligence, Inc., Jan 2011
fibrillation (AF)
- Universal oncology, cardiology, stroke and diabetes molecular imagingagents
- Hand-held, disposable nerve stimulator for use during surgeries
- Polymer-based liquid bandage
